These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32920619)

  • 21. Design and sample size considerations for Alzheimer's disease prevention trials using multistate models.
    Brookmeyer R; Abdalla N
    Clin Trials; 2019 Apr; 16(2):111-119. PubMed ID: 30922116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population.
    Uspenskaya-Cadoz O; Alamuri C; Wang L; Yang M; Khinda S; Nigmatullina Y; Cao T; Kayal N; O'Keefe M; Rubel C
    J Prev Alzheimers Dis; 2019; 6(3):185-191. PubMed ID: 31062833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.
    Vos SJB; Visser PJ
    J Alzheimers Dis; 2018; 64(s1):S213-S227. PubMed ID: 29865060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Epelbaum S; Genthon R; Cavedo E; Habert MO; Lamari F; Gagliardi G; Lista S; Teichmann M; Bakardjian H; Hampel H; Dubois B
    Alzheimers Dement; 2017 Apr; 13(4):454-467. PubMed ID: 28188032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Alzheimer's Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer's-Focused Studies.
    Langbaum JB; High N; Nichols J; Kettenhoven C; Reiman EM; Tariot PN
    J Prev Alzheimers Dis; 2020; 7(4):242-250. PubMed ID: 32920626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
    Ryan JM; Schneider G; Jacobsen JS
    Alzheimers Dement; 2009 Mar; 5(2):140-2. PubMed ID: 19328445
    [No Abstract]   [Full Text] [Related]  

  • 27. The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Fargo KN; Carrillo MC; Weiner MW; Potter WZ; Khachaturian Z
    Alzheimers Dement; 2016 Nov; 12(11):1113-1115. PubMed ID: 27836052
    [No Abstract]   [Full Text] [Related]  

  • 28. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol.
    Solomon A; Kivipelto M; Molinuevo JL; Tom B; Ritchie CW;
    BMJ Open; 2019 Feb; 8(12):e021017. PubMed ID: 30782589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
    Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
    J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recruitment of At-Risk Participants for Clinical Trials: A Major Paradigm Shift for Alzheimer's Disease Prevention.
    Alber J; Lee AKW; Menard W; Monast D; Salloway SP
    J Prev Alzheimers Dis; 2017; 4(4):213-214. PubMed ID: 29181484
    [No Abstract]   [Full Text] [Related]  

  • 31. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.
    Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ;
    Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.
    Cavedo E; Dubois B; Colliot O; Lista S; Croisile B; Tisserand GL; Touchon J; Bonafe A; Ousset PJ; Rouaud O; Ricolfi F; Vighetto A; Pasquier F; Galluzzi S; Delmaire C; Ceccaldi M; Girard N; Lehericy S; Duveau F; Chupin M; Sarazin M; Dormont D; Hampel H;
    J Clin Psychiatry; 2016 Dec; 77(12):e1631-e1638. PubMed ID: 27780331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.
    Grill JD; Zhou Y; Elashoff D; Karlawish J
    Neurobiol Aging; 2016 Mar; 39():147-53. PubMed ID: 26923411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
    Frölich L; Wunderlich G; Thamer C; Roehrle M; Garcia M; Dubois B
    Alzheimers Res Ther; 2019 Feb; 11(1):18. PubMed ID: 30755255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials.
    Weninger S; Carrillo MC; Dunn B; Aisen PS; Bateman RJ; Kotz JD; Langbaum JB; Mills SL; Reiman EM; Sperling R; Santacruz AM; Tariot PN; Welsh-Bohmer KA
    Alzheimers Dement; 2016 May; 12(5):631-2. PubMed ID: 27157073
    [No Abstract]   [Full Text] [Related]  

  • 36. Noncholinergic treatment options for Alzheimer's disease.
    Sano M
    J Clin Psychiatry; 2003; 64 Suppl 9():23-8. PubMed ID: 12934971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Ritchie K; Ropacki M; Albala B; Harrison J; Kaye J; Kramer J; Randolph C; Ritchie CW
    Alzheimers Dement; 2017 Feb; 13(2):186-195. PubMed ID: 27702619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Alzheimer's Disease Cooperative Study in 2004.
    Thal LJ
    Alzheimer Dis Assoc Disord; 2004; 18(4):183-5. PubMed ID: 15592126
    [No Abstract]   [Full Text] [Related]  

  • 39. Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease.
    Vellas B
    J Nutr Health Aging; 2012 Apr; 16(4):330. PubMed ID: 22499451
    [No Abstract]   [Full Text] [Related]  

  • 40. Addressing Health Disparities Among Minority Populations: Why Clinical Trial Recruitment Is Not Enough.
    Wilkins CH; Schindler SE; Morris JC
    JAMA Neurol; 2020 Sep; 77(9):1063-1064. PubMed ID: 32539100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.